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PURPOSE. Trabecular meshwork (TM) cell shape, volume, contractility and their interactions with extracellular matrix determine outflow facility. Because cell volume seems essential to TM function, this study was conducted to investigate further the ionic channels and receptors involved in regulatory volume decrease and their roles in modulating outflow facility. METHODS. Primary cultures of bovine TM cells were used. K ϩ and Cl Ϫ currents were studied with whole-cell patch clamping. Swelling was induced by hypotonic shock. [Ca 2ϩ ] i was measured in TM cells loaded with fura-2. Bovine anterior segments were perfused at constant pressure to measure outflow facility. RESULTS. Hypotonic media activated both the high-conductance Ca 2ϩ -activated K ϩ channel (BK Ca ) and swelling-activated Cl Ϫ channel (Cl swell ) currents and induced release of adenosine 5Ј-triphosphate (ATP) from TM cells. ATP activated P2Y 2 receptors with the following profile: ATP ϭ uridine 5Ј-triphosphate (UTP) Ͼ adenosine 5Ј-O-(3-thiotriphosphate) (ATP-␥ S) Ͼ adenosine 5Ј-diphosphate (ADP) ϭ uridine 5Ј-diphosphate (UDP), and increased BK Ca current. Hypotonic medium initially decreased outflow facility in perfused anterior segments, which recovered with time to baseline levels. Addition of tamoxifen or iberiotoxin (Cl swell and BK Ca blockers, respectively) lengthened the recovery phase, which implies that these channels participate in cell volume regulation. In contrast, an activator of BK Ca s (NS1619) produced the opposite effect. CONCLUSIONS. Cell swelling activates a regulatory volume decrease mechanism that implies activation of K ϩ and Cl Ϫ currents and participation of P2Y 2 receptors. Because previous studies have shown that intracellular volume of TM cells is an important determinant of outflow facility, it seems feasible that cell volume regulation would be part of the homeostatic mechanisms of the TM, to regulate the outflow pathway. I n humans and primates, most of the aqueous humor (AH) produced by the ciliary body flows through the trabecular meshwork (TM) and the Schlemm's canal endothelium to reach the aqueous veins, exiting the eye. The correct performance of this route, as well as the uveoscleral one, is determinant to maintain intraocular pressure (IOP) in the physiological range. On the contrary, when the outflow is somehow impaired, the increase in AH volume raises IOP, which is a major risk factor for the development of glaucoma. TM physiology is still largely unknown, but it has been proposed that TM cells modulate the pathway permeability by showing volume and contractile responses. [1] [2] [3] Several mechanisms have been proposed to play a role in TM function, including contraction/ relaxation of both TM and ciliary muscle 4, 5 ; stretch, 6 ; composition and remodeling of the extracellular matrix [7] [8] [9] ; pore formation in the Schlemm's canal endothelium 10, 11 ; and changes in gene expression, [12] [13] [14] cell shape, 6, 7, 15, 16 or cell volume. 2, 17 Endothelial cells of Schlemm's canal may also participate in the regulation of outflow facility, showing some of these mechanisms, especially in monkey and human eyes, where Schlemm's canal has a higher degree of organization. 18 TM cell volume appears to be an important determinant of tissue function, since swelling or shrinking the cells modifies AH outflow facility. 2, 3 Mitchell et al. 19 recently showed that TM cells possess a regulatory volume decrease (RVD) mechanism. Thus, after cell swelling, the RVD is mediated, at least in part, by activation of swelling-activated Cl Ϫ channels (Cl swell s) and K ϩ -Cl Ϫ symports. In this sense, the Na ϩ /H ϩ antiport has also been suggested to participate in volume regulation, and therefore inhibitors of this antiport may increase outflow facility. 19 Another player is the Na ϩ -K ϩ -Cl Ϫ cotransport that would modulate outflow facility by regulating cell volume in response to different conditions-drugs, 2, 17 but bumetanide (an Na ϩ -K ϩ -Cl Ϫ cotransport blocker) unexpectedly did not have any effect on outflow facility in monkeys. 20 Moreover, bumetanide did not reduce IOP in monkey or mouse. 20, 21 Despite all the players identified and possibly involved in cell volume regulation, a direct relationship between cell volume regulation and outflow facility has not yet been demonstrated.
In other cell types, [22] [23] [24] osmotic cell swelling is thought to activate Cl swell s. Simultaneously, cell swelling induces the release of adenosine 5Ј-triphosphate (ATP) that, in turn, acts as an autocrine/paracrine signal to activate purinergic P2Y receptors. Stimulation of purinergic receptors is thought to facilitate activation of K ϩ channels. Finally, Cl Ϫ and K ϩ efflux from the cell followed by water outflow permits the cell to recover its volume. 25 It remains to be elucidated whether these mechanisms of cell volume regulation are essential to TM function. In this sense, several mechanisms such as the Na ϩ -K ϩ -Cl Ϫ cotransport 17 or the high-conductance Ca 2ϩ -activated K ϩ channel (BK Ca ) 26 are tightly modulated by several drugs, and alterations in their regulation may affect TM function and therefore outflow facility. Our purpose was to identify and characterize the receptors and channels involved in the RVD of TM cells and to determine their functional role in outflow facility modulation as part of an homeostatic system that may regulate TM resistance. We used hypotonic shocks to trigger RVD and to study the receptors and channels involved in this process. Our findings show that changes in TM cell volume modify outflow facility and that regulatory mechanisms to restore cell volume actively participate to maintain AH outflow.
METHODS

Bovine TM Cell Culture
Bovine TM (BTM) cells were cultured by using a modification of the technique described by Stamer et al. 27 As described previously, 4 BTM strips were digested with 2 mg/mL collagenase (Sigma-Aldrich, Madrid, Spain) and 0.5 mg/mL bovine serum albumin (BSA; Sigma-Aldrich) at 37°C for 2 hours. After mechanical digestion, the supernatant was collected, centrifuged, and resuspended. The resuspended solution was seeded in culture flasks containing Dulbecco's modified Eagle's medium (DMEM; BioWhitaker, Barcelona, Spain) plus 10% fetal bovine serum, 100 mg/mL L-glutamine (Sigma-Aldrich), 100 UI/mL penicillin, 100 g/mL streptomycin, and 2.5 g/mL amphotericin B (BioWhitaker). Cell growth was observed 2 to 4 days after seeding and cells reached confluence 12 to 15 days later. Cell passages were performed using trypsin-EDTA (Bio-Whitaker). Cells from passages 1 to 3 were used for electrophysiology, [Ca 2ϩ ] i and ATP measurements.
Cytosolic Free-Ca 2؉ Measurement
Measurement of [Ca 2ϩ ] i was performed as described in detail previously. 4, 28 Briefly, BTM cells were plated on 25-mm diameter glass coverslips (VWR Scientific Inc., Philadelphia, PA) and then loaded with 5 M fura-2/AM (Calbiochem, San Diego, CA) for 60 minutes at 37°C in incubation buffer (121 mM NaCl, 4.7 mM KCl, 5 mM NaHCO 3 , 1.2 mM KH 2 PO 4 , 1.2 mM MgSO 4 , 2 mM CaCl 2 , 10 mM glucose, 10 mM HEPES, and 0.01% BSA [pH 7.4], adjusted with NaOH, 287Ϯ 2 mOsm/ kg; mean Ϯ SD). Coverslips with fura-2-loaded cells were transferred into an open flow chamber (1 mL incubation buffer) mounted on the heated stage of an inverted epifluorescence microscope (Diaphot-300; Nikon, Tokyo, Japan). Fluorescence images were obtained by a chargecoupled device (CCD) camera (CH250; Photometrics, Tucson, AZ) and were digitized, stored, and analyzed on computer (Macintosh 840AV; Apple, Inc., Cupertino, CA). After a stabilization period of 10 minutes, image pairs were obtained alternately every 4 seconds, and, for a total of 8 minutes, at excitation wavelengths of 340 and 380 nm (10-nm bandwidth filters), to excite the Ca 2ϩ -bound and Ca 2ϩ -free forms of this ratiometric dye, respectively. The emission wavelength was 510 nm (120-nm bandwidth filter). [Ca 2ϩ ] i levels were calculated in single cells by determining the 340-to 380-nm fluorescence ratios at each time point. 4, 29 In both control and experimental groups, Ca 2ϩ was recorded for 1 minute before drug application and thereafter, for 7 minutes. Cells were considered as responders when [Ca 2ϩ ] i increased more than 100% above the resting value.
Patch-Clamp Procedures
TM cells were plated onto small glass coverslips and studied 24 to 48 hours thereafter. Coverslips were transferred to a special chamber (0.2 mL) in the stage of an inverted microscope (IX70; Olympus, Tokyo, Japan) to perform the recordings. External solutions were superfused at a rate of 3 to 4 mL/min by gravity. Before the recording session was started, culture medium was replaced with a bath recording solution. Recordings were performed in 2-hour sessions at 21°C to 23°C. Patch pipettes were pulled in an electrode puller (P-97; Sutter Instruments, Novato, CA) and had a filled tip resistance of between 3 to 6 M⍀. Pipette capacitance to ground was neutralized after the seal was formed. An Ag/AgCl wire bath electrode was used except when recording chloride currents where the Ag/AgCl electrode was mounted in a 3 M KCl agar bridge. As previously described, 6 we took care to avoid stretch activation of BK Ca s when performing the patches. Before the pipette had entered the bath and until cell contact, positive pressure was applied.
Whole-cell currents were recorded using a patch-clamp amplifier (L/M-EPC7; Heka, Lambrecht/Pfalz, Germany) as described previously. 6 Data acquisition and command potentials were controlled by computer (WinWCP 3.2 software; John Dempster, University of Strathclyde, UK), using an interface (CED1401; Cambridge Electronic Design Ltd., Cambridge, UK). Whole-cell currents were recorded at 10 kHz.
Chloride Currents
Cl swell currents were recorded using the whole-cell configuration of the patch-clamp technique. After achieving the whole-cell configuration, cells were allowed to stabilize and dialyze for 3 to 4 minutes before recording started. Whole-cell currents were recorded at 10 kHz without any leak current subtraction protocol. Cells were clamped at 0 mV, and voltage pulses from Ϫ80 to ϩ120 mV were applied in 20-mV steps to evoke Cl Ϫ currents. 
Potassium Currents
Potassium currents were recorded in whole-cell configuration, either with the ruptured-patch or the perforated-patch (with Nystatin; SigmaAldrich) technique. Leak current and residual capacitative current were subtracted using a P/N protocol where N was Ϫ4. Cells were clamped at Ϫ60 mV, and depolarizing pulses were applied in 10-or 20-mV steps to evoke outward K ϩ currents. In whole-cell recordings, , with NaOH (291 Ϯ 2.9 mOsm/kg) and allowed to rest for 30 minutes to minimize a possible ATP release due to medium exchange. Twenty percent and 40% hypotonic medium was obtained by adding distilled water to the physiological solution and resulting osmolalities were 242 Ϯ 2 and 206 Ϯ 2 mOsm/kg (mean Ϯ SD), respectively. A vial of firefly lantern luciferase extract from Photinus pyralis (Sigma-Aldrich) was diluted in 1 mL of isotonic physiological solution or distilled water containing 5 mg/mL D-luciferin (SigmaAldrich). The resultiant suspension was centrifuged for 30 seconds in a benchtop centrifuge. The supernatant was desalted in a 10-mL column (10 DG; Bio-Rad, Hercules, CA) equilibrated with recording solution. A photomultiplier tube (R464; Hamamatsu, Hamamatsu City, Japan) located over the Petri dish was used to detect photons. The resultant electric signal was filtered at 1 kHz, digitized, and recorded on computer (X-Chart software; Heka). Calibration curves were calculated by adding known doses of ATP (1, 3, 4, and 6 picomoles).
Regardless of the different ionic strength of the isotonic and hypotonic solutions used, no significant differences were found between the calibration curves in the 1-to 6-picomole range. Therefore, data were not corrected for each solution and all calculations were done with the calibration values in isotonic conditions. Also, to test a possible lysis due to excessive cell swelling when hypotonic solutions were added, we measured lactate dehydrogenase (LDH) activity in the bath solution. 30 No significant amounts of LDH activity were encountered before and after addition of isotonic or hypotonic solutions.
Perfusion of Anterior Segments
Eyes of 3-to 6-month-old calves were obtained at the local abattoir 0.5 to 2 hours after death and kept in phosphate-buffered saline (PBS) at 4°C for not more than 1.5 hours. Isolation of bovine anterior segments was performed as described previously. 3 The perfusion technique has been described elsewhere. 3, 4 Briefly, bovine anterior segments were placed in a specially designed perfusion chamber. The anterior segments, located in their respective chambers together with force transducers (Letica, Barcelona, Spain) and the tubing system, were placed in an incubator (Selecta, Barcelona, Spain) at 36°C and 5% CO 2 . Perfusion was performed with DMEM. The pressure of the artificial anterior chamber was monitored and recorded throughout the experiment with a pressure transducer (9162-0; Mallinckrodt, Northampton, UK) and was maintained with a suspended reservoir at 10 mm Hg in bovine eyes. Outflow facility (C) was averaged during periods of 15 minutes (mean of 450 values). Baseline facility (C 0 ) was calculated during the first 90-minute period of stable C. When a different experimental condition or drug was added to the perfusion medium, the tubes and the anterior chamber were flushed and replaced with the new medium. This change was made by rapidly replacing the contents of the artificial anterior chamber by opening the exit needle until 200% of the volume had been exchanged. This exchange was always made at a pressure below 10 mm Hg. Recording of C started after stabilization of the flow.
The perfusion procedure was performed using a protocol with two periods: perfusion with control isotonic DMEM (301 Ϯ 1 mOsm/kg) for 90 minutes, to establish the C 0 , and perfusion with hypotonic (244 Ϯ 2 mOsm/kg) DMEM for 360 minutes to determine changes in outflow facility after five experimental conditions: hypotonic medium, hypotonicϩtamoxifen, hypotonicϩIBTX, hypotonicϩtamoxifenϩIBTX, and hypotonicϩBK Ca channel opener (NS1619; 1,
Drugs
ATP, uridine 5Ј-triphosphate (UTP), adenosine 5Ј-O-(3-thiotriphosphate) (ATP-␥ S), adenosine 5Ј-diphosphate (ADP), uridine 5Ј-diphosphate (UDP), suramin sodium salt, 2-MeS-ATP (2-methylthio adenosine 5Ј-triphosphate tetrasodium salt), thapsigargin, EGTA, U73122
IBTX, firefly lantern extract (luciferin-luciferase), the BK Ca channel opener NS1619, nystatin, and ARL67156, were obtained from Sigma-Aldrich. PPADS (pyridoxal-phosphate-6-azophenyl-2Ј,4Ј-disulfonic acid) was purchased from Calbiochem.
Data Analysis
Results are given as the mean Ϯ SEM. Data were analyzed with the paired or unpaired Student's t-test, the Fisher exact test, and the 2 test. Two-way ANOVA with the Bonferroni posttest was used to evaluate differences between control and drug effects in the recorded currents. P Ͻ 0.05 was considered statistically significant.
RESULTS
Modulation of K
؉ and Cl ؊ Currents in the TM by Cell Swelling
It has been reported that hypotonicity triggers an RVD 19 in TM cells and that it also decreases outflow facility in perfused anterior segments. 2, 3 In the present study, we further examined the effects of hypotonic stimuli on whole-cell currents mediated by the BK Ca 6 and the possible activation of Cl swell in TM cells. As shown in Figure 1A , whole-cell currents were first recorded in isotonic physiological solution (control) and afterward bath solution was replaced by hypotonic medium. Cells were clamped at Ϫ60 mV, and depolarizing pulses to ϩ80 mV were applied in 10-mV steps to evoke outward BK Ca currents. In hypotonic medium, the total outward K ϩ current increased significantly (ANOVA; P Ͻ 0.001) in 13 of 15 whole-cell experiments (87% of the cells). Bonferroni posttests showed significant differences between the isotonic and hypotonic groups, at Ϫ10 mV (P Ͻ 0.05) and from 0 to ϩ80 mV (P Ͻ 0.001). Two of 15 cells did not show significant changes. Figure 1A shows a typical recording and the current-voltage (I-V) relationship in isotonic and hypotonic conditions. In agreement with previous data, 6, 19 hypotonic solution did not modify [Ca 2ϩ ] I ; thus, it is not likely that the BK Ca current increase was due to an increase in [Ca 2ϩ ] i . In a different set of experiments, cells were voltage clamped at 0 mV, and whole-cell currents were elicited by using specific solutions to record Cl Ϫ currents (see the Methods section). Under isotonic conditions, TM cells possessed a small current of Ϫ3.0 Ϯ 1.3 pA/pF (mean Ϯ SEM) at an applied potential of Ϫ80 mV and 2.8 Ϯ 1.2 pA/pF at ϩ80 mV (Fig. 1B) . When isotonic medium was replaced by a hypotonic one, Cl swell currents were activated within 4 minutes and reached a maximum between 10 and 12 minutes (Ϫ8.2 Ϯ 2.1 pA/pF at Ϫ80 mV and 14.4 Ϯ 4.3 pA/pF at ϩ80 mV; mean Ϯ SEM). Accounting all the cells recorded in the whole study, Cl swell current activation was seen in 140 (85%) of 164 cells. In the experimental group shown in Figure 1B , cells in isotonic medium (n ϭ 5) were first exposed to hypotonic medium and, on maximum Cl swell current activation, hypotonic medium was replaced, returning to isotonic medium. Statistical comparison of the I-V curves in isotonic and hypotonic conditions showed significant differences for the whole voltage range (Ϫ80 to ϩ120 mV; ANOVA, P Ͻ 0.001). Bonferroni posttests showed significant differences between the isotonic and hypotonic groups, at ϩ80 mV (P Ͻ 0.01) and ϩ120 mV (P Ͻ 0.001; Fig.  1B ). When returning to isotonic medium, Cl swell currents decreased, and significant differences between isotonic and hypotonic conditions were also recorded at ϩ80 mV (P Ͻ 0.01) and ϩ120 mV (P Ͻ 0.001). All recordings were obtained with ATP and GTP in the intracellular solution. In a group of recordings (n ϭ 5) where these compounds were omitted, no Cl swell Ϫ replacement in the hypotonic solution (SEM was omitted for clarity). Calculation of reversal potential (V rev ) and relative anion permeabilities (P x /P Cl ; Fig. 2, table) showed an anion permeability sequence I Ϫ Ͼ Br Ϫ Ͼ Cl Ϫ Ͼ F Ϫ Ͼ gluconate Ϫ , which is in agreement with previous data for this channel. [32] [33] [34] Pharmacological characterization of Cl swell currents is shown in Figure 3 . After activation of Cl swell currents in hypotonic solution, Cl Ϫ channel blockers were added to the solution, and their effects at depolarized and hyperpolarized potentials were evaluated. Tamoxifen (100 M; n ϭ 5), a known selective Cl swell blocker, decreased outward and inward Cl swell currents in a voltage-independent manner along the entire I-V relationship (ANOVA P Ͻ 0.001, hypotonic versus hypotonicϩtamoxifen). As shown in Figure 3A , tamoxifen blocked Cl swell currents both at hyperpolarized (55% at Ϫ80 mV; t-test, P Ͻ 0.05 vs. hypotonic) and depolarized potentials (60% at ϩ80 mV; t-test, P Ͻ 0.05). Next, we tested the effect of DIDS, a nonselective Cl Ϫ channel blocker. By contrast, addition of DIDS (100 M; n ϭ 6 cells) to the hypotonic medium significantly blocked only the outward currents (ANOVA, I-V relationship hypotonicϩDIDS versus hypotonic, P Ͻ 0.001). DIDS decreased outward current by 40% (at ϩ80 mV; t-test, P Ͻ 0.05), but did not affect inward current (6% at Ϫ80 mV; t-test, NS). Blocking effects of both tamoxifen and DIDS are characteristic of Cl swell currents, as described previously. 35 These results are in agreement with electrophysiological characterization and further corroborate that the currents recorded are mediated by Cl swell channels. To characterize the currents further, we tested the effect of extracellularly applied ATP (1 mM), which has also been reported to block Cl swell currents. 32 Extracellular ATP blocked Cl swell currents in a voltage-dependent manner along the entire I-V curve (ANOVA, P Ͻ 0.001; n ϭ 6; Fig. 3C ). Extracellular ATP blocked Cl swell currents both at hyperpolarized (28% at Ϫ80 mV; t-test, P Ͻ 0.05 vs. hypotonic) and depolarized potentials (52% at ϩ80 mV; t-test, P Ͻ 0.01).
Cell Swelling's Effects on ATP Release in TM Cells
It has been reported that ATP can be released to function as an autocrine/paracrine signal in several cell types after osmotic challenge or in response to drug stimulation. 25, 36 In TM cells grown in 35-mm culture dishes, DMEM was replaced by an isotonic physiological solution (see the Methods section), and cells were allowed to rest for 30 minutes to minimize a possible ATP release due to medium exchange. Stimulation of TM cells with isotonic medium did not elicit a significant release of ATP into the extracellular solution (0.004 Ϯ 0.0006 picomoles or 0.001 Ϯ 0.002 nM; mean Ϯ SEM; n ϭ 3; Figs. 4A, 4B). When medium hypotonicity was reduced by 20%, 2.76 Ϯ 0.18 picomoles of ATP was released (1.15 Ϯ 0.07 nM; t-test P Ͻ 0.001 vs. isotonic; n ϭ 5). After reaching a peak, ATP release decreased exponentially to recover baseline levels within 400 to 500 seconds after stimulation. When medium hypotonicity was reduced by 40%, 4.35 Ϯ 0.23 picomoles of ATP was released, showing the same kinetics (1.56 Ϯ 0.08 nM; t-test P Ͻ 0.001 vs. isotonic; n ϭ 4). ) and were recorded in six TM cells. Note that some Cl swell currents inactivated at strong depolarized potentials (hypotonic in A), but the common pattern was an increasingly rapid inactivation as the depolarization increased (hypotonic in B and C). Significant differences were recorded between isotonic and hypotonic medium (*P Ͻ 0.05; t-test) and between hypotonic medium and hypotonicϩblocker ( ϩ P Ͻ 0.05 and , and 40% hypotonic (n ϭ 4) media. Significant differences were found between isotonic and hypotonic stimulations (***P Ͻ 0.001; t-test). Fig. 5G , Table 1 ). Finally, we tested ATP application in the presence of well-known purinergic receptor antagonists (Table  1; Figs. 5E-G). In the presence of 100 M suramin, the percentage of response to ATP application decreased to 69% (P Ͻ 0.05 vs. ATP alone) while PPADS did not modify the percentage of responding cells to ATP when present in the bath solution. These results show a response profile to the different nucleotides as ATPϷUTPϾ ATP-␥-SϾϾADPϷUDP which suggests the presence of a P2Y 2 purinergic receptor. Moreover, as described previously, 37 P2Y 2 receptors are partially inhibited by suramin but not by PPADS, which argues in favor of the presence of those receptors. Also, the effect of 2-MeS-ATP suggests the presence of P2Y 1 receptors.
We further examined the intracellular mechanisms involved in the ATP-induced [Ca 2ϩ ] i increase in TM cells. In nominally Ca 2ϩ -free solution (ϩ1 mM EGTA), both ATP and ATP-␥-S (1 M), stimulated the same percentage of cells as ATP in the normal buffer solution (Table 1) . No differences were seen on intracellular Ca 2ϩ peak amplitude compared with ATP in the presence of calcium. Nevertheless, recovery phase to resting [Ca 2ϩ ] i was shorter than with ATP in normal buffer solution (Fig. 6A ). An ATP-induced [Ca 2ϩ ] i increase was prevented by preincubation of cells with thapsigargin (P Ͻ 0.001; Table 1 , Figs. 6A, 6B) . A significant decrease in the percentage of cells that had increased [Ca 2ϩ ] i after ATP exposure was seen in the presence of U73122, an inhibitor of phospholipase C, 38 (P Ͻ 0.001) and CPA, a Ca 2ϩ -ATPase inhibitor, 39 (P Ͻ 0.001), but not after preincubation with ryanodine.
As previously stated, hypotonic stimuli did not modify [Ca 2ϩ ] i , which is inconsistent with release of ATP. To explore this possibility, we measured [Ca 2ϩ ] i after a hypotonic stimuli. (Fig. 6C) . Ca 2ϩ peaks elicited by hypotonic stimuli in the presence of ARL67156 were blocked by suramin (100 M).
ATP Increases BK Ca Current
One of the possible ATP functions after activation of purinergic receptors, in particular, would be to increase K ϩ efflux from the cell thus contributing to cell volume recovery. We performed experiments to test this hypothesis using the wholecell perforated patch technique, which prevents dialysis of intracellular content. After achieving this configuration, we clamped TM cells at Ϫ60 mV and BK Ca currents were recorded in resting conditions with a physiological solution in the bath (n ϭ 6; Fig. 7A ). Superfusion of ATP at 10 M significantly increased BK Ca currents along the I-V relationship (ANOVA P Ͻ 0.001 vs. baseline physiological solution) in seven (78%) of nine cells tested. Bonferroni posttests showed significant differences at ϩ60 (P Ͻ 0.05), ϩ80 (P Ͻ 0.01), and ϩ100 (P Ͻ 0.001) mV versus the baseline recording. After drug washout, BK Ca currents returned to baseline values, as can be seen in the recording and I-V plot displayed in Figure 7A . Next, we performed experiments in the presence of suramin (100 M; n ϭ 5; Fig. 7B ) to test the receptor-mediated effect of ATP. After recording BK Ca currents in physiological solution (baseline) and in the presence of suramin (no effect was seen in the presence of suramin alone), we applied ATP at the same concentration as that used in the previous experiment. In the presence of the blocker, ATP induced a slight nonsignificant increase in BK Ca currents (Fig. 7B) . These results confirm that the effects on BK Ca currents are mediated through activation of specific purinergic receptors present in TM cells.
Participation of RVD Mechanisms in Outflow Facility Modulation
It has been reported that hypotonic medium decreases outflow facility. 2, 3 In the current study, we perfused eye anterior segments (n ϭ 6) for 90 minutes, to establish baseline outflow facility and therefore isotonic perfusion medium (301 Ϯ 1 mOsm/kg) was replaced with a hypotonic one (244 Ϯ 2 mOsm/kg) and maintained during 360 minutes (Fig. 8A) . This moderate hypotonic shock decreased outflow facility significantly at 15 minutes (20%, P Ͻ 0.001; Fig. 8 ), and then it recovered gradually to baseline levels (3% over baseline outflow facility, t-test, NS). The results obtained permitted us to hypothesize that outflow facility is closely linked to TM cell volume and that RVD mechanisms may contribute to recovery of outflow facility after hypotonic shock or other insults that may affect cell volume. We tested this hypothesis by adding drugs known to block or activate selectively the ionic channels that participate in RVD mechanisms. Anterior segments (n ϭ 6) perfused in the presence of 100 M tamoxifen showed a more pronounced decrease in outflow facility (25%, P Ͻ 0.001) after 15 minutes in hypotonic medium compared with the perfusions with hypotonic medium alone (Figs. 8A, 8B ). More interesting, they did not recover baseline outflow facility even after 360 minutes (12% below baseline values; P Ͻ 0.001 vs. hypotonic medium). Similar results were obtained when hypotonic medium was supplemented with IBTX (10 nM). When both drugs (IBTX and tamoxifen) were added together (n ϭ 6), not only was the initial decrease in outflow facility more pronounced than in the previous groups (34%, P Ͻ 0.001), but the recovery phase was the slowest. After 360 minutes, outflow facility was still 17% below baseline (P Ͻ 0.001). On the contrary, perfusion with hypotonic medium plus a BK Ca channel opener (NS1619; 30 M, n ϭ 6) showed opposite results. The initial decrease in outflow facility was smaller than in hypotonic medium alone (14%, P Ͻ 0.001) and recovery to baseline was faster than in the absence of the drug. In fact, outflow facility achieved baseline within Ϸ45 minutes after hypotonic shock (Figs. 8A, 8B ).
DISCUSSION
In this study, cellular mechanisms involved in TM cell volume regulation were essential in determining AH outflow facility. We put together data from the cellular level with measurements of AH evacuation showing that modulation of certain channels or receptors may have a great influence on outflow facility. Different factors have been involved in modulating outflow resistance through the TM (see the introduction). 40 Several studies 2, 3, 17, 19 have focused on the changes in TM cell volume, since previous data from our laboratory 3 and others 2, 3, 19 have shown that osmolality changes in the perfusion medium evoke swelling or shrinkage of TM cells that modify outflow facility. Also, it has been reported that TM cells trigger an RVD mechanism in response to osmotic insults that may be involved in outflow facility modulation. 19 In fact, several different membrane proteins that are thought to participate in cell volume regulation have been identified in TM cells, such as the BK Ca channel, 6 ,26 a Cl Ϫ swell channel, 19 an Na ϩ -K ϩ -2Cl Ϫ symport, 17 an Na ϩ /H ϩ antiport, 41 a K ϩ -Cl Ϫ symport, 19 and a Cl Ϫ /HCO 3 Ϫ exchanger. 19 Moreover, other mechanisms such as ATP release from nerve terminals or due to cell swelling may also be involved in cell volume regulation. 23, 25 AH appears to be slightly more hypertonic than plasma, 42, 43 and it is likely that changes in AH tonicity influence TM cell volume, although they have not been described to date. More important may be drug-induced changes in TM cell volume (e.g., norepinephrine and adenosine agonists). 17, 40, 44 O'Donnell et al. 17 showed that bumetanide, ethacrynic acid, 8Br-cAMP, and 8Br-cGMP among others, decreases volume in cultured TM cells through inhibition of the Na ϩ -K ϩ -2Cl Ϫ symport. In contrast, phorbol 12-myristate 13-acetate (PMA) increases cell volume. Bumetanide also increases outflow facility in human and calf eyes. 2 Moreover, it has been reported recently that adenosine receptor agonists cause cell shrinkage in TM cells, probably because of Ca 2ϩ influx and Cl Ϫ efflux. 40 In fact, the adenosine agonist cyclohexyladenosine (CHA) has been reported to increase outflow facility in rabbit eyes, 45 but it is unknown whether this effect is due to changes in cell volume in the TM. All these results seem to agree that TM cell shrinkage increases outflow facility, whereas cell swelling decreases it, as previously reported by changing perfusate osmolality. 2, 3 Our results show cell swelling activates two ionic conductances: a BK Ca and a Cl swell . As described in several cell types, K ϩ and Cl Ϫ effluxes are accompanied by water to restore normal cell volume (RVD). 23, 25 In particular, BK Ca currents had an approximately threefold increase over the resting values in isotonic medium. Cell swelling activated Cl swell as soon as 4 minutes after bath exchange to hypotonic medium and reached a maximum between 10 and 12 minutes. Cl swell currents decreased when returning to isotonic medium (Fig. 1B) showing that their activation is a reversible process. Also, the effects of well-known blockers (tamoxifen and DIDS) of Cl swell currents and their ionic selectivity are in agreement with previous reports in TM cells 19 and other cell types. 35 Special mention should be made to the effects of extracellular ATP on Cl swell currents. After activation by hypotonicity, addition of ATP to the recording bath partially blocked Cl swell currents (Fig. 3C) . This effect has also been previously described, 46, 47 but its physiological relevance is unknown. We have also found, as previously reported (Cui M, et al. IOVS 2001;42: ARVO Abstract 743), 40 that hypotonic stimuli trigger the release of ATP from TM cells. ATP, through activation of purinergic receptors, increased BK Ca currents (Fig. 7) , perhaps contributing to the RVD. Nevertheless, the increase of ATP concentration in the extracellular environment may be part of a physiological mechanism to prevent excessive activation of Cl swell currents, since the blocking effect is only at high concentrations (in the millimolar range) but not at lower concentrations (micromolar) where the effect is to stimulate BK Ca currents. It should be mentioned that in the absence of hypotonic stimulus, ATP (in micromolar concentrations) activates Cl swell currents in TM cells (data not shown) as seen in other studies. 48 We should note that ATP can be released due to mechanical stimulation in TM cells ( Also, we cannot exclude that ATP can be liberated on cell stimulation with several agonists, as seen in other cell types. 36 Therefore, it can be hypothesized that ATP acts in an autocrine/paracrine manner in the TM, regulating outflow facility by volume changes in TM cells. Moreover, Fleischhauer et al. 40 have recently shown that released ATP may be a source of adenosine and that adenosine agonists reduce TM cell volume.
Results obtained in the present study coincide with a profile for a P2Y 2 receptor. The presence of this receptor has been suggested (Cui M, et al. IOVS 2001;42:ARVO Abstract 743), and its activation leads to stimulation of phospholipase C, release of calcium from intracellular stores (IP 3 -sensitive), and sustained influx of extracellular Ca 2ϩ (Fig. 6 ). The characteristics of [Ca 2ϩ ] i mobilization triggered by ATP and UTP are similar to the ones induced by other drugs such as bradykinin, 4 carbachol, 51 or adenosine agonists. 40 As previously mentioned, ATP stimulation of TM cells increased BK Ca currents. This effect was partially blocked in the presence of suramin, implying a receptor-mediated mechanism. It is possible that BK Ca s were stimulated directly due to the increase in [Ca 2ϩ ] i , but it is also possible that purinergic receptor stimulation triggers an intracellular cascade of second messengers to activate BK Ca s, probably through PKC. These two possibilities, which remain to be tested, are not exclusive, and both may be involved in the same final effect on BK Ca s. Of note, ATP released by hypotonic stimuli did not increase [Ca 2ϩ ] i in TM cells, probably due to a rapid degradation of this nucleotide by nucleotidases. Experiments performed with an inhibitor of nucleotidases in the hypotonic solution showed Ca 2ϩ peaks with characteristics similar to the ones elicited by ATP. This fact suggests that in cultured cells ATP is rapidly cleaved but in vivo locally released ATP may be sufficient to stimulate purinergic receptors and activate BK Ca currents. Further investigation should be conducted to describe the transduction pathway. In this study, BK Ca s were involved in ATP signaling and volume regulation, but they have also been shown to mediate the effects of purinergic agonists, 40 nitric oxide, 26 tyrosine kinase, 52 and flufenamic acid 53 and to detect membrane stretching. 6 Therefore, BK Ca s play a central role in many processes in TM cells, probably regulating the contractile state and cellular volume. Taken together, these effects would finally regulate the AH outflow through the TM.
Hypotonic solutions decrease outflow facility 2, 3 and after an initial decline (Fig. 8) , this parameter recovers to achieve baseline levels within Ϸ2 hours, probably due to an RVD mechanism in TM cells, as shown by Mitchell et al. 19 Outflow facility did not recover in the presence of tamoxifen, a Cl swell blocker, and/or IBTX, a BK Ca blocker. The initial decrease in FIGURE 8. Influence of RVD mechanisms on modulation of outflow facility. (A) Outflow facility ratio (normalized with baseline outflow facility) is plotted against time. Anterior segments were perfused with control medium (DMEM) for 90 minutes (baseline), and then perfusion medium was replaced (arrow) by hypotonic DMEM with or without drugs, and the solution was maintained until the end of the experiment. Data are shown for hypotonic (n ϭ 6), hypotonicϩtamoxifen (100 M, n ϭ 6), hypotonicϩtamoxifenϩIBTX (10 nM, n ϭ 6), hypotonicϩBK Ca opener (NS1619, 30 M, n ϭ 6), and hypotonicϩIBTX (10 nM, n ϭ 6). The initial decrease in outflow facility was reversed in the presence of K ϩ and Cl Ϫ channel blockers. Also, recovery phase to baseline was impaired in the presence of the blockers. On the contrary, the BK Ca channel opener decreased the initial decline in outflow facility in hypotonic medium and shortened the recovery phase. (B) Mean Ϯ SEM outflow facility ratios measured after 15 minutes in the hypotonic medium (or hypotonic mediumϩdrugs) and after 360 minutes of perfusion in hypotonic medium. Time after 15 minutes is representative of the initial decrease in outflow facility due to hypotonic medium. Measures after 360 minutes in hypotonic medium are representative of the recovery phase. Significant differences (t-tests) are shown between each group and the control group (baseline in isotonic medium): *P Ͻ 0.05, **P Ͻ 0.01, ***P Ͻ 0.001.
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outflow facility after 15 minutes in hypotonic medium is even greater in the presence of Cl Ϫ and K ϩ blockers (Figs. 8A, 8B) suggesting that RVD quickly activates to recover cell volume, which shows a direct correlation with outflow facility values. The opposite occurs when using NS1619, a BK Ca activator, the initial decrease in outflow facility is smaller and the time to recover baseline values is shorter. Therefore, activators of BK Ca s may exert a protective effect against osmotic insults or drugs that modify cellular volume. 40 It may also be possible that activators of BK Ca s like nitric oxide or cGMP may be endogenously released to modulate outflow facility, although further investigations are necessary to test this hypothesis. Finally, specific activators of Cl swell (unknown to date with the exception of ATP at low concentrations 48 ) would also be interesting molecules to modulate outflow facility. Because TM function can be modulated by changes in cell volume, selective drugs targeting cell volume regulatory mechanisms would increase outflow facility without damaging either the cells or the extracellular matrix. The present results and others 17, 19, 20, 40, 44, 53 support this idea. In summary, our findings show that cellular mechanisms that regulate cell volume in TM cells play an important role in outflow facility regulation. In particular, K ϩ and Cl Ϫ channel activation is directly involved in the recovery of baseline outflow facility after hypotonic shock. Therefore, cell volume regulation appears to be part of the homeostatic mechanisms involved in the regulation of the outflow pathway, actively contributing to TM function.
